Cargando…
Ibrutinib synergizes with poly(ADP-ribose) glycohydrolase inhibitors to induce cell death in AML cells via a BTK-independent mechanism
Targeting Bruton's tyrosine kinase (BTK) with the small molecule BTK inhibitor ibrutinib has significantly improved patient outcomes in several B-cell malignancies, with minimal toxicity. Given the reported expression and constitutive activation of BTK in acute myeloid leukemia (AML) cells, the...
Autores principales: | Rotin, Lianne E., Gronda, Marcela, MacLean, Neil, Hurren, Rose, Wang, XiaoMing, Lin, Feng-Hsu, Wrana, Jeff, Datti, Alessandro, Barber, Dwayne L., Minden, Mark D., Slassi, Malik, Schimmer, Aaron D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4823070/ https://www.ncbi.nlm.nih.gov/pubmed/26624983 http://dx.doi.org/10.18632/oncotarget.6409 |
Ejemplares similares
-
Oncogenic activity of poly (ADP-ribose) glycohydrolase
por: Marques, Maud, et al.
Publicado: (2018) -
The structure and catalytic mechanism of a poly(ADP-ribose) glycohydrolase
por: Slade, Dea, et al.
Publicado: (2011) -
Selective Down-Regulation of Nuclear Poly(ADP-Ribose) Glycohydrolase
por: Burns, David M., et al.
Publicado: (2009) -
Crystallographic and Biochemical Analysis of the Mouse Poly(ADP-Ribose) Glycohydrolase
por: Wang, Zhizhi, et al.
Publicado: (2014) -
The Ups and Downs of Tannins as Inhibitors of Poly(ADP-Ribose)glycohydrolase
por: Blenn, Christian, et al.
Publicado: (2011)